Skip to main content

Rett In The News

UCLA
UCLA researchers identify an experimental drug that improves abnormal neural oscillations found in Rett brain organoids.
Taysha Gene Therapies
Taysha Gene Therapies announces ambitious timeline of starting Rett syndrome gene replacement clinical trial by year end and reporting clinical data by end of 2022.
Endpoints News
Two years after spinning out of CRISPR pioneer Prashant Mali’s lab, Shape Therapeutics has a lot more cash and a slightly new mission. They have lead programs in Rett syndrome and Parkinson’s.
Endpoints News
In downtown Lowell, MA, tucked into one of the country’s oldest surviving textile mill complexes is a new biotech toiling away on next-gen CNS therapies for severe neurological disorders. And it’s starting with Rett syndrome — a rare neurodevelopmental condition that almost exclusively ...

Recent Articles

Home
MECP2 reactivation is a cornerstone therapeutic strategy at RSRT. The fact that this strategy ...
Home
Rett Syndrome is considered a rare disease; yet rare diseases, as a whole, are not rare—they ...
Home
A key aspect of effective clinical trials is the ability to objectively and accurately measure ...
Home
We are aware of concerns about the adenovirus vector COVID-19 vaccine from Johnson & ...
Home
Dear families and supporters, We want to share with you the update below from Novartis Gene ...
Home
I have had the privilege of working with the Rett Syndrome Research Trust (RSRT) for the past ...